Pathology of Breast Cancer: Subtypes, Receptors, Biologic Markers, and Staging

Omid Bakhtar

doi:10.1016/j.suc.2022.08.001

Review Article| Volume 103, ISSUE 1, P1-15, February 2023

Pathology of Breast Cancer

Subtypes, Receptors, Biologic Markers, and Staging

Omid Bakhtar, MD, MS
Omid Bakhtar
Contact
Affiliations
Sharp Healthcare, Surgical Pathology and Laboratory Medicine, 5651 Copley Drive, Suite B, San Diego, CA 92111, USA
Search for articles by this author

Published:October 17, 2022DOI:https://doi.org/10.1016/j.suc.2022.08.001

Keywords

To read this article in full you will need to make a payment

Purchase one-time access:

One-time access price info

For academic or personal research use, select 'Academic and Personal'
For corporate R&D use, select 'Corporate R&D Professionals'

Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

Content published before 2002 is available via pay-per-view purchase only.

Subscribe:

Already a print subscriber? Claim online access

Already an online subscriber? Sign in

Register: Create an account

Institutional Access: Sign in to ScienceDirect

References

- Schnitt S.J.
- Brogi E.
- Chen Y.Y.
- et al.
American registry of pathology expert opinions: the spectrum of lobular carcinoma in situ: diagnostic features and clinical implications.
Ann Diagn Pathol. 2020; 45: 151481
View in Article
- Arps D.P.
- Jorns J.M.
- Zhao L.
- et al.
Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast.
Ann Surg Oncol. 2014; 21: 4152-4158
View in Article
- Krings G.
- Bean G.R.
- Chen Y.Y.
Fibroepithelial lesions; The WHO spectrum.
Semin Diagn Pathol. 2017; 34: 438-452
View in Article
- WHO Classification of Tumors Editorial Board
WHO classification of tumors.
5th edition. International Agency for Research on Cancer, Lyon2019 (Breast tumors)
View in Article
- Google Scholar
- Page D.L.
- Salhany K.E.
- Jensen R.A.
- et al.
Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma.
Cancer. 1996; 78: 258-266
View in Article
- Li X.
- Xu Y.
- Ye H.
- et al.
Encapsulated papillary carcinoma of the breast: A clinicopathological study of 49 cases.
Curr Probl Cancer. 2018; 42: 291-301
View in Article
- Oldenhuis C.N.
- Oosting S.F.
- Gietema J.A.
- et al.
Prognostic versus predictive value of biomarkers in oncology.
Eur J Cancer. 2008; 44: 946-953
View in Article
Amin M.B. Edge S.B. Greene F.L. AJCC cancer staging manual. 8th edition. Springer, New York2017
View in Article
- Crossref
- Google Scholar
- Allison K.H.
- Hammond M.E.H.
- Dowsett M.
- et al.
Estrogen and progesterone receptor testing in breast cancer: american society of clinical oncology/college of american pathologists guideline update.
Arch Pathol Lab Med. 2020; 144: 545-563
View in Article
- Wolff A.C.
- Hammond M.E.H.
- Allison K.H.
- et al.
Human epidermal growth factor receptor 2 testing in breast cancer: american society of clinical oncology/college of american pathologists clinical practice guideline focused update.
Arch Pathol Lab Med. 2018; 142: 1364-1382
View in Article
- Peppercorn J.
- Perou C.M.
- Carey L.A.
Molecular subtypes in breast cancer evaluation and management: divide and conquer.
Cancer Invest. 2008; 26: 1-10
View in Article

Article info

Publication history

Published online: October 17, 2022

Identification

DOI: https://doi.org/10.1016/j.suc.2022.08.001

Copyright

ScienceDirect

Access this article on ScienceDirect

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes